[
  {
    "ts": null,
    "headline": "Edward Lifesciences: A Closer Look At Growth And Valuation",
    "summary": "Financial writer's analysis of Edward Lifesciences stock: Hold rating due to valuation, core segment growth, and potential for share buybacks.",
    "url": "https://finnhub.io/api/news?id=178baacdf1e1daaa0150297286ef5131e6c8c9eab20881e5babfa7b0c4a020aa",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736080053,
      "headline": "Edward Lifesciences: A Closer Look At Growth And Valuation",
      "id": 132279066,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1795167728/image_1795167728.jpg?io=getty-c-w1536",
      "related": "EW",
      "source": "SeekingAlpha",
      "summary": "Financial writer's analysis of Edward Lifesciences stock: Hold rating due to valuation, core segment growth, and potential for share buybacks.",
      "url": "https://finnhub.io/api/news?id=178baacdf1e1daaa0150297286ef5131e6c8c9eab20881e5babfa7b0c4a020aa"
    }
  }
]